EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization

Sara Dionne iD, Hillary Akana iD, Kaitlin Logue iD, Brenden O'Neale iD, Chris Curran iD, Sean VanSlyck iD

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Sara Dionne und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eurofins Donor & Product Testing, LLC, Centennial, Colorado, USA. Hauptthemen laut MEDLINE: Tissue Donors, Organ Transplantation, Donor Selection, Tissue and Organ Procurement. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nucleic acid testing (NAT) is essential for detecting transmissible viral infections in deceased organ donors and guiding safe organ allocation. However, invalid discriminatory NAT (dNAT) results may lead to unnecessary donor exclusion and reduced organ availability.

Methods

We performed a retrospective analysis of HIV‐1/2, HBV, and HCV NAT results from deceased organ donors in the United States. Donor specimens were tested at eleven laboratories using FDA‐approved donor screening assays. Donor serologic results and organ utilization outcomes were reviewed to evaluate the clinical impact of invalid dNAT results.

Results

Invalid dNAT results occurred in 0.027% of donor cases ( n = 27), predominantly in cases suggestive of HCV infection ( n = 22). Although infrequent, these cases had a disproportionate impact on organ utilization. Serologic findings frequently supported true infection despite unresolved NAT results. Repeat testing did not resolve these cases and extended result reporting times by a median of 22 h. In 30% of cases ( n = 6) in which organ utilization was available, organs were not transplanted, reflecting uncertainty in infectious risk assessment.

Conclusion

Although rare, invalid dNAT results have clinical and operational consequences, contributing to delays, conservative donor classification, and reduced organ utilization. These findings highlight the need for standardized reporting of invalid results and access to rapid alternative confirmatory testing to support informed clinical decision‐making and reduce unnecessary organdiscard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue DonorsOrgan TransplantationDonor SelectionTissue and Organ ProcurementNucleic Acid Amplification TechniquesHumansRetrospective StudiesHepatitis CUnited StatesHepatitis B virusFemaleHepacivirusHepatitis BHIV InfectionsHIV-1Male

Stichwörter der Autor:innen

donor eligibilitydonor screeninginfectious diseasenucleic acid testingorgan transplantation

Autor:innen und Institutionen

  • Eurofins Donor & Product Testing, LLC, Centennial, Colorado, USA.
  • New England Donor Services, Waltham, Massachusetts, USA.
  • Sierra Donor Services, Sacramento, California, USA.

ORCID-Profile: Sara Dionne, Hillary Akana, Kaitlin Logue, Brenden O'Neale, Chris Curran, Sean VanSlyck

Zitieren

APA

Dionne, S., Akana, H., Logue, K., O'Neale, B., Curran, C., & VanSlyck, S. (2026). Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization. Transplant Infectious Disease. https://doi.org/10.1111/tid.70247

Vancouver

Dionne S, Akana H, Logue K, O'Neale B, Curran C, VanSlyck S. Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization. Transplant Infectious Disease. 2026. doi:10.1111/tid.70247

BibTeX
@article{Dionne2026,
  author = {Dionne, Sara and Akana, Hillary and Logue, Kaitlin and O'Neale, Brenden and Curran, Chris and VanSlyck, Sean},
  title = {Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70247}
}
Kostenlos starten →